Edition:
United Kingdom

Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

38.60PLN
15 Feb 2019
Change (% chg)

0.80zł (+2.12%)
Prev Close
37.80zł
Open
38.20zł
Day's High
41.00zł
Day's Low
38.20zł
Volume
168,681
Avg. Vol
12,419
52-wk High
41.00zł
52-wk Low
28.10zł

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 31.70 0.184
Jun '18 30.24 0.169
Mar '18 28.17 0.168
FY 2017 Dec '17 25.91 0.139
Sep '17 24.21 0.109
Jun '17 28.61 0.187
Mar '17 28.39 0.112
 
*Note: Units in Millions ofPolish Zloty
**Note: Units in Polish Zloty

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 2 157.63 164.10 151.16 --
Earnings (per share)
Year Ending Dec-19 2 0.93 1.00 0.86 --
Sales and Profit Figures in Polish Złoty (PLN);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 40.59 30.48 33.70
P/E High - Last 5 Yrs. -- 44.98 49.87
P/E Low - Last 5 Yrs. -- 23.63 24.25
Beta -- 0.90 0.90
Price to Sales (TTM) 13.07 4.12 6.29
Price to Book (MRQ) 3.70 5.10 5.26
Price to Tangible Book (MRQ) 3.73 5.85 6.77
Price to Cash Flow (TTM) 35.44 24.01 24.98
% Owned Institutions -- 0.90 1.69

Dividends

  Company industry sector
Dividend Yield 0.51 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.15 4.85
Payout Ratio(TTM) 0.00 43.91 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -32.12 4.31 12.75
Sales (TTM) vs TTM 1 Yr. Ago -- 4.07 5.84
Sales - 5 Yr. Growth Rate -- 10.91 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -78.37 44.94 47.15
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 10.31 10.85
Capital Spending - 5 Yr. Growth Rate -- 15.88 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 20.88 2.15 2.25
Current Ratio (MRQ) 22.56 2.97 3.08
LT Debt to Equity (MRQ) 0.00 8.84 11.38
Total Debt to Equity (MRQ) 0.00 12.89 16.12
Interest Coverage (TTM) -- 33.79 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 8.65 53.68 53.81
Gross Margin - 5 Yr. Avg. -- 51.67 52.18
EBITD Margin (TTM) 41.72 -- --
EBITD - 5 Yr. Avg -- 17.96 12.87
Operating Margin (TTM) 28.55 14.31 6.20
Operating Margin - 5 Yr. Avg. -- 14.24 8.31
Pre-Tax Margin (TTM) 29.15 14.85 7.16
Pre-Tax Margin - 5 Yr. Avg. -- 14.68 8.61
Net Profit Margin (TTM) 23.71 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.89
Effective Tax Rate (TTM) 18.64 23.02 22.91
Effective Tax Rate - 5 Yr. Avg. -- 23.16 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 957,645,487 842,398,385
Net Income/Employee (TTM) -- 113,564,537 99,842,801
Receivable Turnover (TTM) 5.20 5.71 5.71
Inventory Turnover (TTM) 2.82 2.61 3.47
Asset Turnover (TTM) 0.36 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 8.54 11.52 11.06
Return on Assets - 5 Yr. Avg. -- 12.92 12.20
Return on Investment (TTM) 8.97 14.95 14.45
Return on Investment - 5 Yr. Avg. -- 16.84 15.87
Return on Equity (TTM) 10.50 16.27 15.96
Return on Equity - 5 Yr. Avg. -- 17.77 17.00
  1 Year 3 Year 5 Year
Sales % 1.64 -- --
EPS (TTM) % -9.78 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Celon Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.46 -9.67 27 22
13 Week -8.49 -13.82 64 39
26 Week -12.44 -19.46 67 33
52 Week -- -- -- 9
YTD 36.68 9.74 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 16.39%
# of Holders: 11
Total Shares Held: 7,377,664
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.